News Diagonal Bio AB

Equities

DIABIO

SE0015961826

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
0.026 ^SEK	-2.26%		-8.13%	-92.63%

Jun. 11	Diagonal Bio AB Approves the Board Member Karin Wehlin Declines Re-Election	CI
May. 31	Diagonal Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB	Jun. 11	AQ
Diagonal Bio AB Approves the Board Member Karin Wehlin Declines Re-Election	Jun. 11	CI
Diagonal Bio AB first quarter (Q1 2024)	May. 31	AQ
Diagonal Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 31	CI
Diagonal Bio appoints new CFO	May. 23	AQ
Diagonal Bio AB Appoints Fata Mrsic as Chief Financial Officer, Effective June 14, 2024	May. 23	CI
Diagonal Bio announces strategic pilot study with Löberöds Hästklinik	May. 15	AQ
Diagonal Bio Announces Strategic Pilot Study with Löberöds Hästklinik	May. 15	CI
Diagonal Bio AB Annual Report 2023	May. 15	AQ
Diagonal Bio AB announces last day of trading in BTU and first day of trading in TO 1	May. 07	AQ
Diagonal Bio AB announces outcome of rights issue	Apr. 24	AQ
Diagonal Bio AB publish - White paper	Apr. 16	AQ
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand	Apr. 10	AQ
The subscription period in Diagonal Bio AB rights issue commences today	Apr. 08	AQ
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic	Apr. 05	AQ
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	Apr. 05	CI
Diagonal Bio AB Announces Successful Pilot Study Results	Apr. 05	CI
Diagonal Bio AB publishes a prospectus because of upcoming rights issue	Apr. 03	AQ
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB	Apr. 02	AQ
Diagonal Bio Makes Interim CEO Permanent	Feb. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Diagonal Bio AB

Equities

DIABIO

SE0015961826

Summary

Filters